The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
|Articles|June 20, 2013
FDA Clears Carestream’s Small Digital Radiography Detector
Author(s)Diagnostic Imaging Staff
Carestream received FDA clearance for a new wireless digital radiography detector designed for low-dose pediatric exams.
Advertisement
Carestream received FDA clearance for a new wireless digital radiography detector designed for low-dose pediatric exams.
The smaller detector, which is expected to begin shipping in the third quarter of this year, is also designed for orthopedic and general radiology applications. For pediatric exams, the detector can fit into a tray under an incubator in the pediatric ICU, according to the company.
The DRX2530C detector measures 25 cm x 30 cm and has high detective quantum efficiency (DQE) which can lead to lower doses than computed radiography cassettes or gadolinium scintillator detectors, the company said.
For orthopedic and general exams, the detector can be positioned for tabletop exams such as knee, elbow, and skull.
“The new DRX 2530C detector addressed a need voiced by healthcare providers worldwide for a smaller detector that could deliver important imaging advantages in pediatric and orthopedic environments,” Diana L. Nole, president of Carestream’s digital medical solutions, said in a statement.
Advertisement
Related to this article
In a new podcast episode, Amir Iravani, MD, FRACP, discusses emerging dosimetry data from the COMPETE trial for 177Lu-edotreotide and how it may help facilitate more personalized treatment for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.
AI has to do more than show potential. It has to deliver measurable results.The Rad AI Outcomes and Market Impact Compendium brings together real-world clinical, operational and financial evidence from health systems, academic medical centers and radiology practices using Rad AI Reporting, Impressions and Continuity.Explore results including 60+ minutes saved per radiologist shift, a 47% reduction in report error rates, 70%+ patient follow-up adherence and >7x ROI — plus, case studies showing how organizations are translating AI into greater capacity, quality and financial performance.See what AI built specifically for radiology can deliver in practice.
Catch up on the top radiology content of the past week.
Assessing breast MRI scans, pathology and clinical data, the AI-powered TumorSight Risk software reportedly provides five- and 10-year risk for breast cancer recurrence for women with HR+, HER2-negative stage I-IIIA breast cancer.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
2
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
3
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
4
See the Real-World Impact of AI in Radiology
5